Sysmex South Africa
Menu

OSNA in breast cancer

Axillary management and the relevance of sentinel lymph node biopsy (SLNB) have undergone major changes in the last years. Clinical trials, which have investigated less invasive treatment approaches as a replacement of axillary surgery, indicate that axillary dissection can be omitted in patients with limited metastatic involvement. Consequently, treatment decisions and nodal staging more often have to be based solely on the diagnostic information derived from the sentinel lymph node (SLN).

More than 100 publications provide evidence on the clinical utility of using OSNA and the CK19 copy number for SLN assessment. They show that CK19 provides predictive and prognostic information beyond conventional pathology assessment. This helps clinicians better select who can be safely spared an ALND, allows more personalised treatment decisions and improves patients’ quality of life.

Features

Do you get all this from your current sentinel lymph node analysis? CK19 mRNA expression level:

Excellent diagnostic information

  • More accurate determination of the metastatic burden by analysis of the entire lymph node
  • Standardised, objective assessment of lymph node status

Confidence

  • Fast availability of results for optimal decision making on the right surgical/ non-surgical approach
  • Confident staging as reliable basis for therapy choice

Patient quality of life

  • Permits earlier start of further therapy measures
  • Reduced waiting time and less patient stress

 

Contacts
You have a question and would like to get in touch with our experts? We look forward to receiving your enquiry.

Sysmex South Africa (Pty) Ltd

Fernridge Office Park, Block 1,

Randburg 2194

+27 (11) 329 94 80

Documents

Product documents

Safety data sheets

Regulatory Documents

Regulatory documents, such as Instructions for Use, can be accessed with a valid My Sysmex login:

Go to My Sysmex

Explore more

Sentimag - Magseed in breast cancer

Sentimag - Magseed in breast cancer

Sentimag / Magseed - Magnetic lesion and lymph node localisation

Details
OSNA in gynaecological

OSNA in gynaecological

Lymph node assessment beyond ultra-staging

Details
Copyright © Sysmex Europe SE. All rights reserved.